Taking aged garlic extract might slow down the hardening of your heart arteries and help lower your blood pressure by making dangerous fatty buildups in your arteries more stable and less likely to...
Claim Context
Aged garlic extract supplementation reduces progression of coronary artery calcification and improves blood pressure by stabilizing vulnerable atherosclerotic plaques.
“aged garlic extract can stabilize vulnerable plaques. And there was another randomized control trial that showed that the group that was randomized to take an aged garlic extract for one year had a lower progression of coronary artery calcification and improve blood pressure.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (2)
Community contributions welcome
Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: A randomized, double-blind, placebo-controlled study
Aged garlic extract retards progression of coronary artery calcification.
Contradicting (0)
Community contributions welcome
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether aged garlic extract directly reduces progression of coronary artery calcification and improves blood pressure compared to placebo, with plaque stabilization as a mechanistic endpoint.
Enroll 500 adults with subclinical atherosclerosis (CAC score 100–400), randomly assign to aged garlic extract (1200 mg/day standardized allicin content) or placebo for 24 months. Primary outcomes: change in CAC score via CT angiography; secondary outcomes: change in systolic/diastolic BP. Mechanistic endpoint: serial high-resolution intravascular ultrasound (IVUS) or optical coherence tomography (OCT) on a subset (n=100) to quantify plaque composition (lipid core, fibrous cap thickness) and inflammation markers (e.g., macrophage infiltration) at baseline and 24 months. All participants undergo standardized BP monitoring and lipid panels. Blinded adjudication of imaging outcomes.
Whether long-term aged garlic extract use correlates with slower plaque progression and improved BP, and whether changes in plaque stability biomarkers mediate these effects.
Recruit 1000 middle-aged adults with early atherosclerosis (CAC >0) from community clinics. Collect self-reported aged garlic extract use (dose and duration) at baseline and annually. Perform annual non-invasive carotid and coronary CT angiography to track CAC progression and plaque morphology (e.g., low-attenuation plaque, positive remodeling). Measure plasma biomarkers of plaque stability (MMP-9, CRP, oxidized LDL, soluble CD40L) and BP at each visit. Use mediation analysis to test if changes in biomarkers explain the association between garlic use and CAC/BP outcomes. Adjust for confounders (diet, statins, smoking).
The pooled effect size of aged garlic extract on CAC progression and BP, and whether studies reporting plaque stability markers show consistent trends.
Systematically identify all published and unpublished RCTs (n≥30) testing aged garlic extract in humans with baseline and follow-up CAC or carotid IMT measurements. Extract data on dosage, duration, BP changes, and any reported plaque imaging or biomarker outcomes. Pool standardized mean differences for CAC progression and BP change using random-effects models. Subgroup analysis: studies that measured plaque stability markers (e.g., fibrous cap thickness, lipid core volume) vs. those that did not. Assess publication bias and heterogeneity. Only include trials with ≥12 months duration and validated imaging methods.
Whether aged garlic extract directly stabilizes plaques and reduces calcification in a controlled setting with direct tissue analysis.
Use ApoE−/− mice fed high-fat diet. Randomize into three groups: control diet, control diet + aged garlic extract (equivalent human dose: 1200 mg/day), and positive control (atorvastatin). Treat for 16 weeks. Perform serial micro-CT to quantify aortic calcification. Harvest aortas for histology: measure plaque area, fibrous cap thickness, collagen content, macrophage density, and calcification via von Kossa staining. Analyze serum cytokines and oxidative stress markers. Compare changes between groups using ANOVA. Include immunohistochemistry for MMP-9 and TIMP-1 to assess plaque stability pathways.
Whether bioactive compounds in aged garlic extract directly modulate plaque stability pathways in human vascular cells.
Treat human primary vascular smooth muscle cells and monocyte-derived macrophages with standardized aged garlic extract (or its active compounds: S-allyl cysteine, S-allyl mercaptocysteine) at physiologically relevant concentrations (0.1–10 µM). Measure: 1) collagen and elastin production (qPCR, ELISA); 2) MMP-2/9 and TIMP-1/2 secretion (zymography, ELISA); 3) lipid uptake and foam cell formation (Oil Red O); 4) inflammatory cytokine release (IL-6, TNF-α). Include inhibitors of Nrf2 and NF-κB pathways to test mechanistic involvement. Compare to untreated and statin-treated controls.